Registry for Advanced Sarcodiosis

Inclusion criteria

- Patients with diagnosis of sarcoidosis based on ATS/WASOG criteria 22

- Age ≥ 18 years.

- Life expectancy of at least 2 years.

- Pulmonary function tests (spirometry) within one month of entry or willing to under
pulmonary function testing on the day of study enrollment

- Sarcoidosis as characterized as either advanced or non-advanced (see protocol for
definition of advanced disease)

- Subjects must be able to understand and be willing to sign the written informed
consent form. A signed informed consent form must be appropriately obtained prior to
the conduct of any trial-specific procedure.

Exclusion criteria

- Subjects with a medical disorder, condition, or history of such that would impair the
subject's ability to participate or complete this study in the opinion of the
investigator

- Inability to comply with the protocol and/or not willing or not available for
follow-up assessments.

- Any condition which, in the investigator's opinion, makes the subject unsuitable for
trial participation.